Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6974 USD | +1.07% |
|
-46.35% | -94.59% |
28/06 | Tonix Pharmaceuticals Closes $4 Million Offering | MT |
27/06 | Top Midday Decliners | MT |
Sales 2024 * | 1.39Cr 115.97Cr | Sales 2025 * | 1.78Cr 148.2Cr | Capitalization | 29.19L 24Cr |
---|---|---|---|---|---|
Net income 2024 * | -7.9Cr -658.35Cr | Net income 2025 * | -9.1Cr -758.35Cr | EV / Sales 2024 * | 0.21 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.16 x |
P/E ratio 2024 * |
-0.02
x | P/E ratio 2025 * |
-0.03
x | Employees | 103 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.17% |
1 day | +1.07% | ||
1 week | -46.35% | ||
Current month | -86.62% | ||
1 month | -87.18% | ||
3 months | -88.28% | ||
6 months | -94.70% | ||
Current year | -94.59% |
![Extreme 0.595](/images/extremecours_fleche.png)
![Extreme 0.595](/images/extremecours_fleche.png)
![Extreme 0.595](/images/extremecours_fleche.png)
![Extreme 0.595](/images/extremecours_fleche.png)
![Extreme 0.595](/images/extremecours_fleche.png)
![Extreme 0.595](/images/extremecours_fleche.png)
![Extreme 0.595](/images/extremecours_fleche.png)
Date | Price | Change | Volume |
---|---|---|---|
28/24/28 | 0.6974 | +1.07% | 1,556,650 |
27/24/27 | 0.69 | -38.67% | 8,457,488 |
26/24/26 | 1.125 | -10.00% | 2,116,602 |
25/24/25 | 1.25 | +5.04% | 492,178 |
24/24/24 | 1.19 | -8.46% | 936,057 |
Delayed Quote Nasdaq, June 29, 2024 at 01:30 am IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.59% | 29.19L | |
+2.99% | 9.52TCr | |
-4.34% | 3.75TCr | |
-10.41% | 3.38TCr | |
+75.79% | 2.82TCr | |
-14.61% | 1.56TCr | |
-3.46% | 1.36TCr | |
-12.31% | 1.15TCr | |
+184.77% | 1.08TCr | |
-54.13% | 923.34Cr |
- Stock Market
- Equities
- TNXP Stock